Company Monitoring Page for ASCO

latest headlines for company on cafepharma

Novartis bone marrow drug improves progression-free survival
Yahoo/Reuters
Mon, 06/2/14 - 10:04 am
Tags:
Novartis, LBH589, Multiple Myeloma, ASCO
Clovis' Lung Cancer Bravado Falls Flat With New Diabetes Revelation
TheStreet.com
Mon, 06/2/14 - 09:44 am
Tags:
Clovis Oncology, diabetes, CO-1686, AZD9291, lung cancer, ASCO
U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors
Yahoo/Reuters
Mon, 06/2/14 - 09:42 am
Tags:
Yervoy, brain cancer, immunotherapy, Bristol-Myers Squibb, ASCO, nivolumab
AbbVie releases interim results from Phase Ib trial of ABT-199/GDC-0199
Yahoo/Fly on the Wall
Mon, 06/2/14 - 09:40 am
Tags:
AbbVie, ABT-199, GDC-0199, B-cell lymphoma, ASCO
AstraZeneca Cancer News Boosts Soriot’s $45 Billion Case
Bloomberg
Mon, 06/2/14 - 09:27 am
Tags:
AstraZeneca, Pascal Soriot, ASCO, cancer, Pfizer
Drug flops from 2004 haunt AstraZeneca investors
Yahoo/Reuters
Tue, 05/20/14 - 09:47 am
Tags:
AstraZeneca, ASCO, Exanta
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
Thu, 05/15/14 - 08:29 am
Tags:
ASCO, Gilead Sciences, AbbVie, Pharmacyclics, Imbruvica, CLL, Idelalisib, mantle cell lymphoma, ABT-199
Bristol, Merck, Roche immune therapies are cancer meeting focus
Yahoo/Reuters
Thu, 05/15/14 - 08:24 am
Tags:
Bristol-Myers Squibb, Merck, Roche, ASCO, cancer, anti-PD-1 immunotherapy
[video]ASCO Abstracts: Bristol-Myers Squibb's and Merck's Immuno-Oncology Drugs
Motley Fool
Wed, 05/14/14 - 08:22 am
Tags:
ASCO, Bristol-Myers Squibb, Merck, immuno-oncology
Cancer Doctors Plan to Compare Value of Expensive Drugs
Bloomberg
Wed, 04/16/14 - 05:17 pm
Tags:
cancer, physicians, ASCO
Are pricey cancer drugs worth the cost? ASCO means to find out
Fierce Pharma
Wed, 03/26/14 - 12:40 pm
Tags:
ASCO, drug pricing
Infinity Pharmaceuticals And IPI-145: ASCO 2013 Highlights
Seeking Alpha
Mon, 06/10/13 - 11:00 am
Tags:
ASCO, Infinity Pharmaceuticals, Gilead, IPI-145
ASCO Stocks That Should Sizzle in the Future
Motley Fool
Mon, 06/10/13 - 10:12 am
Tags:
ASCO, Merck, Clovis Oncology, Bristol-Myers Squibb
Celgene at ASCO: Ho-Hum, Ho-Hum, and Hmmm
Motley Fool
Wed, 06/5/13 - 12:24 pm
Tags:
Celgene, ASCO, Pomalyst, Abraxane, Revlimid
Clovis Oncology Skyrockets After ASCO Presentations
Seeking Alpha
Tue, 06/4/13 - 12:28 pm
Tags:
ASCO, Clovis Oncology, CO-1686, rucaparib
Analyst: Cancer Drugs Push Investors Into Pharma
Barron's
Tue, 06/4/13 - 10:00 am
Tags:
cancer, ASCO, Merck, Bristol-Myers Squibb
Two Diversified Biotechs to Watch After Impressive ASCO Data
Motley Fool
Mon, 06/3/13 - 12:36 pm
Tags:
ONYX Pharmaceuticals, Nexavar, tergenpumatucel-L, NewLink Genetics, ASCO
Merck jumps on melanoma treatment results
Marketwatch
Mon, 06/3/13 - 11:26 am
Tags:
Merck, melanoma, lambrolizumab, ASCO
Cancer Drug Shortages Force Doctors to Ration, Delay Treatment
Bloomberg
Mon, 06/3/13 - 10:59 am
Tags:
drug shortages, ASCO, physicians
Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.
TheStreet.com
Mon, 06/3/13 - 10:20 am
Tags:
nivolumab, Merck, melanoma, lambrolizumab, Bristol-Myers Squibb, ASCO

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.